Research Title: A Genetic Screening and Registry Study to Evaluate Long-term Clinical Outcomes and Disease Progression in Subjects with Non-Central Geographic Atrophy (GA) Who are Carriers of High-Risk Genetic Complement Variants Associated with Dry Age-related Macular Degeneration (AMD)
Sponsor: Gemini Therapeutics, Inc.
Principal Investigator: Robert Stoltz, M.D., Ph.D.
Description: This is a prospective, multicenter, longitudinal registry, conducted in subjects with non-central GA secondary to dry AMD, who are carriers of known genetic variants associated with AMD. The registry is designed to identify dry AMD subjects with high-risk genetic variants, who may also be appropriate study subjects for the prospective natural history (NH) study (GEM-NH-002) and future interventional studies.
Start Date: June 2019
Project Personnel: Leslie Marcus, CCRC; Caitlin Harrison, CCRC, COA; Stephanie Campbell, CRC, COA; Amber Adams, CRC, COA
Location(s): Marietta; 833 Campbell Hill Street, Suite 300, Marietta, GA 30060